|
ZNF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.244200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.903200E-01 |
| Normal-vs-Stage2 |
7.551600E-02 |
| Normal-vs-Stage3 |
1.098360E-03 |
| Normal-vs-Stage4 |
4.06729999999911E-05 |
| Stage1-vs-Stage2 |
1.180820E-01 |
| Stage1-vs-Stage3 |
3.415300E-04 |
| Stage1-vs-Stage4 |
3.02979999999842E-06 |
| Stage2-vs-Stage3 |
3.121600E-01 |
| Stage2-vs-Stage4 |
1.091350E-01 |
| Stage3-vs-Stage4 |
4.158000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.140400E-02 |
| Normal-vs-AfricanAmerican |
1.649170E-01 |
| Normal-vs-Asian |
2.296200E-01 |
| Caucasian-vs-AfricanAmerican |
8.012400E-01 |
| Caucasian-vs-Asian |
5.070400E-02 |
| AfricanAmerican-vs-Asian |
1.239790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.678300E-02 |
| Normal-vs-Female |
3.266200E-02 |
| Male-vs-Female |
8.776400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.814200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.255600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.364400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.244200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.235800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.908200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.464600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.360100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.108560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.508600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.898300E-02 |
| Normal-vs-Grade 2 |
6.531800E-01 |
| Normal-vs-Grade 3 |
2.157300E-03 |
| Normal-vs-Grade 4 |
1.58920000048468E-07 |
| Grade 1-vs-Grade 2 |
6.520400E-02 |
| Grade 1-vs-Grade 3 |
4.581800E-04 |
| Grade 1-vs-Grade 4 |
1.116760E-03 |
| Grade 2-vs-Grade 3 |
8.621900E-04 |
| Grade 2-vs-Grade 4 |
6.46099995726956E-09 |
| Grade 3-vs-Grade 4 |
1.895200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.793200E-01 |
| Normal-vs-ccB subtype |
2.223800E-03 |
| ccA subtype-vs-ccB subtype |
2.41329999999262E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.611800E-02 |
| Normal-vs-N1 |
4.937700E-02 |
| N0-vs-N1 |
4.499600E-01 |
|
|
